Watkins Frank T's Form 4 filing
Shockwave Medical, Inc. (SWAV) · filed Oct 21, 2021
- Accession no.
- 0000950103-21-016222
- Filed
- Oct 21, 2021
- Trade date
- Oct 19-20, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 14 non-derivative transactions and 0 derivative transactions. Open-market sales total $802.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Watkins Frank TCIK 0001305831 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 19, 2021 | Common Stock | SSaleDisposed | −495 | $198.86 | −$98,435.7 | 63,307 | Direct | |
| Oct 19, 2021 | Common Stock | SSaleDisposed | −287 | $199.75 | −$57,328.25 | 63,020 | Direct | |
| Oct 19, 2021 | Common Stock | SSaleDisposed | −117 | $200.83 | −$23,497.11 | 62,903 | Direct | |
| Oct 19, 2021 | Common Stock | SSaleDisposed | −320 | $201.96 | −$64,627.2 | 62,583 | Direct | |
| Oct 19, 2021 | Common Stock | SSaleDisposed | −398 | $202.89 | −$80,750.22 | 62,185 | Direct | |
| Oct 19, 2021 | Common Stock | SSaleDisposed | −338 | $203.81 | −$68,887.78 | 61,847 | Direct | |
| Oct 19, 2021 | Common Stock | SSaleDisposed | −45 | $204.91 | −$9,220.95 | 61,802 | Direct | |
| Oct 20, 2021 | Common Stock | SSaleDisposed | −185 | $195.01 | −$36,076.85 | 61,617 | Direct | |
| Oct 20, 2021 | Common Stock | SSaleDisposed | −147 | $196.58 | −$28,897.26 | 61,470 | Direct | |
| Oct 20, 2021 | Common Stock | SSaleDisposed | −325 | $198.06 | −$64,369.5 | 61,145 | Direct | |
| Oct 20, 2021 | Common Stock | SSaleDisposed | −465 | $198.97 | −$92,521.05 | 60,680 | Direct | |
| Oct 20, 2021 | Common Stock | SSaleDisposed | −89 | $200.08 | −$17,807.12 | 60,591 | Direct | |
| Oct 20, 2021 | Common Stock | SSaleDisposed | −417 | $201.80 | −$84,150.6 | 60,174 | Direct | |
| Oct 20, 2021 | Common Stock | SSaleDisposed | −372 | $202.65 | −$75,385.8 | 59,802 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.